Smoking Cessation Duration and Diabetic Microvascular Complications - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Impact of Smoking Cessation Duration on Microvascular Complications in Diabetes

  • By

  • Soonsu Shin

  • Min-Ho Kim

  • Jae-Hong Ryoo

  • October 2, 2026

Share

Objective:

To examine the relationship between the duration of smoking cessation and incident diabetic microvascular complications in patients with type 2 diabetes.

Approach:
  • Study Design: A retrospective cohort study using the National Health Insurance Service database in Korea, focusing on adults aged 40 years or older diagnosed with type 2 diabetes from 2003 to 2013.
  • Participant Selection: Participants were included based on consistent smoking status across repeated health checkups, with specific categories for never smokers, quitters, and continuous smokers.
  • Data Collection: Smoking status was assessed through self-administered questionnaires during national health checkups, and incident diabetic microvascular complications were identified using diagnostic codes.
  • Cessation Duration: For sustained quitters, cessation duration was categorized into intervals from less than 2 years to 8 years or more.
Key Findings:
  • Cigarette smoking increases the risk of diabetic nephropathy, retinopathy, and neuropathy.
Limitations:
  • The study relies on retrospective data, which may introduce biases.
  • Informed consent was waived due to the use of anonymized data.

Original Source(s)

Related Content